Literature DB >> 9316934

Failure to detect Chlamydia trachomatis in cell culture by using a monoclonal antibody directed against the major outer membrane protein.

J Boman1, C Gaydos, P Juto, G Wadell, T C Quinn.   

Abstract

Two commercially available monoclonal antibodies for cell culture confirmation of Chlamydia trachomatis were compared in two prospective studies and one large retrospective study. In total, more than 33,000 genital specimens were cultured in parallel and stained with both antibodies, one of which was directed against the major outer membrane protein (MOMP) and one of which was directed against the lipopolysaccharide (LPS). We found the anti-LPS-based assay to be more sensitive and as specific as the anti-MOMP-based assay for C. trachomatis cell culture confirmation of genital specimens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316934      PMCID: PMC230037          DOI: 10.1128/jcm.35.10.2679-2680.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion.

Authors:  C A Gaydos; L Bobo; L Welsh; E W Hook; R Viscidi; T C Quinn
Journal:  Sex Transm Dis       Date:  1992 Nov-Dec       Impact factor: 2.830

2.  Under-diagnosis of female genital Chlamydia trachomatis infection.

Authors:  C Y Tong; I A Tait
Journal:  Genitourin Med       Date:  1996-04

3.  Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera.

Authors:  M F Lampe; K G Wong; L M Kuehl; W E Stamm
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

4.  Staining characteristics of six commercially available monoclonal immunofluorescence reagents for direct diagnosis of Chlamydia trachomatis infections.

Authors:  L D Cles; K Bruch; W E Stamm
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture.

Authors:  G S Montalban; P M Roblin; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

6.  Differences in clinical manifestations of genital chlamydial infections related to serovars.

Authors:  M J van de Laar; Y T van Duynhoven; J S Fennema; J M Ossewaarde; A J van den Brule; G J van Doornum; R A Coutinho; J A van den Hoek
Journal:  Genitourin Med       Date:  1996-08

7.  Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships.

Authors:  T C Quinn; C Gaydos; M Shepherd; L Bobo; E W Hook; R Viscidi; A Rompalo
Journal:  JAMA       Date:  1996-12-04       Impact factor: 56.272

8.  Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay.

Authors:  R C Barnes; S P Wang; C C Kuo; W E Stamm
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

9.  Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization.

Authors:  R S Stephens; M R Tam; C C Kuo; R C Nowinski
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

  9 in total
  2 in total

1.  Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women.

Authors:  K A Crotchfelt; B Pare; C Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

2.  Evaluation of the digene hybrid capture II CT-ID test for detection of Chlamydia trachomatis in endocervical specimens.

Authors:  J L Girdner; A P Cullen; T G Salama; L He; A Lorincz; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.